Alkermes plc. Payment for Debt Extinguishment or Debt Prepayment Cost
Alkermes plc. (ALKS) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $993.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2024-02-21
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-12-31 was $0.00.
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-09-30 was $16.00K.
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-06-30 was $715.00K.
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-03-31 was $262.00K.
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for fiscal 2021 was $993.00K.
- Alkermes plc. payment for debt extinguishment or debt prepayment cost for fiscal 2016 was $65.81M.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month | Payment for Debt Extinguishment or Debt Prepayment Cost 9 month | Payment for Debt Extinguishment or Debt Prepayment Cost 12 month | Payment for Debt Extinguishment or Debt Prepayment Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $16.00K derived: sum of 2 quarters · filed 2024-02-21 | $731.00K derived: sum of 3 quarters · filed 2024-02-21 | $993.00K 10-K · filed 2024-02-21 | |
| 2021-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $731.00K derived: sum of 2 quarters · filed 2022-11-02 | $993.00K 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $977.00K 10-Q · filed 2022-07-27 | |||
| 2021-03-31 | $262.00K 10-Q · filed 2022-04-27 | ||||
| 2016-12-31 | $65.81M 10-K · filed 2018-02-16 | $3.43M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |